Literature DB >> 11162826

Kinetic analyses of stability of simple and complex retroviral vectors.

F Higashikawa1, L Chang.   

Abstract

Simple and complex retroviral vectors derived from Moloney murine leukemia virus (MLV) and human immunodeficiency virus type 1 (HIV-1), respectively, are useful tools for gene transfer studies. However, factors affecting the stability of these vectors have not been carefully investigated. Here we studied the stability factors on vesicular stomatitis viral envelope glycoprotein (VSV-G)-pseudotyped MLV- and HIV-1-derived vectors. Analysis of the ratio of defective particles versus infectious units using electron microscopy and a functional transduction assay revealed that both vectors consisted of high numbers of defective particles ( approximately 100-350:1), which could be reduced ( approximately 10-20:1) by centrifugation. Frequent freeze-and-thaw rapidly decreased vector titer in the first three to five cycles and stabilized thereafter. Both viral vectors were sensitive to temperatures above 37 degrees C but more stable at temperatures below 37 degrees C, exhibiting a two-phase inactivation kinetic starting with a steep inactivation phase, followed by a more leveled phase. Interestingly, HIV-1-derived vectors were significantly more stable than MLV-derived vectors at higher temperatures (>37 degrees C). Both vectors were rapidly destabilized at pH either below or above 7.0. Incubation with human or mouse serum significantly inhibited VSV-G-pseudotyped vector activities. Preheated human serum still reduced vector half-lives to approximately 50% (150 min), suggesting that certain inactivation factors are not heat-labile. Analyses of these stability factors may improve future production and applications of retroviral and lentiviral vectors. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11162826     DOI: 10.1006/viro.2000.0743

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  41 in total

1.  Using Pulmozyme DNase treatment in lentiviral vector production.

Authors:  Aaron Shaw; Daniela Bischof; Aparna Jasti; Aaron Ernstberger; Troy Hawkins; Kenneth Cornetta
Journal:  Hum Gene Ther Methods       Date:  2012-02       Impact factor: 2.396

2.  Synchronized infection of cell cultures by magnetically controlled virus.

Authors:  Hillel Haim; Israel Steiner; Amos Panet
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

3.  Transduction efficiency of pantropic retroviral vectors is controlled by the envelope plasmid to vector plasmid ratio.

Authors:  Yong Chen; William M Miller; Ashok Aiyar
Journal:  Biotechnol Prog       Date:  2005 Jan-Feb

4.  Efficiency of human immunodeficiency virus type 1 postentry infection processes: evidence against disproportionate numbers of defective virions.

Authors:  James A Thomas; David E Ott; Robert J Gorelick
Journal:  J Virol       Date:  2007-01-31       Impact factor: 5.103

5.  Prolonged adherence of human immunodeficiency virus-derived vector particles to hematopoietic target cells leads to secondary transduction in vitro and in vivo.

Authors:  Yung-Wei Pan; Jarrad M Scarlett; Tammy T Luoh; Peter Kurre
Journal:  J Virol       Date:  2006-10-11       Impact factor: 5.103

6.  Lentivirus immobilization to nanoparticles for enhanced and localized delivery from hydrogels.

Authors:  Seungjin Shin; Lonnie D Shea
Journal:  Mol Ther       Date:  2010-01-05       Impact factor: 11.454

7.  Reducing the genotoxic potential of retroviral vectors.

Authors:  Ali Ramezani; Teresa S Hawley; Robert G Hawley
Journal:  Methods Mol Biol       Date:  2008

8.  Faster generation of hiPSCs by coupling high-titer lentivirus and column-based positive selection.

Authors:  Emily Dick; Elena Matsa; Lorraine E Young; David Darling; Chris Denning
Journal:  Nat Protoc       Date:  2011-05-05       Impact factor: 13.491

Review 9.  Methods for gene transfer to the central nervous system.

Authors:  Boris Kantor; Rachel M Bailey; Keon Wimberly; Sahana N Kalburgi; Steven J Gray
Journal:  Adv Genet       Date:  2014       Impact factor: 1.944

10.  Expression of YB-1 enhances production of murine leukemia virus vectors by stabilizing genomic viral RNA.

Authors:  Wei Li; Xinlu Wang; Guangxia Gao
Journal:  Protein Cell       Date:  2012-12-08       Impact factor: 14.870

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.